MTOR and head and neck squamous cell carcinoma: Studies in HNSCC patients have revealed a similar phenomenon, indicating that overexpressed proteins in the PI3K/AKT/mTOR signaling pathway, such as p-mTOR and p-AKT, may be used as good prognostic biomarkers [26].